Delivery Order SPE2DB22D1002-SPE2DB25FLGD8
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials valued at $2,939.10. This competitively awarded, firm fixed-price contract is scheduled for completion by July 23, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, PA. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for M-M-R II vaccine vials with a ceiling value of $2,330.79. This firm fixed-price delivery order, which is not associated with any set-aside designation, is expected to be completed by August 12, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,763.46 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 11, 2025. This firm fixed-price contract, awarded on August 8, 2025, represents a non-set-aside competitive procurement with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for M-M-R II vaccine vials with a ceiling value of $126,439.10. This firm fixed-price delivery order, which is a non-set-aside competitive award, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of M-M-R II vaccine vials, with a ceiling value of $4,185.90. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $15,484.70 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials under a firm fixed-price contract on August 15, 2025, with an ultimate completion date of August 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $1,789.29 under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a non-set-aside competitive award, and performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The $1,537.14 delivery order was placed against an existing contract with Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. No set-aside designation was used. The delivery order will be performed at Amerisourcebergen's corporate office in Conshohocken,...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGD8Delivery Order
The Defense Logistics Agency awarded a $3,950.31 delivery order for M-M-R II vaccine vials to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and related medical commodities. This specific delivery order for M-M-R II vaccine vials supports the military's immunization requirements and reflects the company's ongoing role as a key pharmaceutical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/12/25 |